Ceapro Inc V.CZO

Alternate Symbol(s): CRPOF

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > Is March the month?

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Feb 28, 2024 8:19pm

28 Views

Post# 35905290

RE:Is March the month?

The closing of the merger is expected in April so April may be when it all comes together.

prophetoffactz wrote: - March 8 is the vote.
- New name for the company.
- 5X PGX commissioning by the end of March. Gilles has previously indicated that the 5X scale-up provides partners with materials to work with. CZO has also designed an animal trial protocol for the immune booster and may need this material. Closing of the merger would provide CZO with capital and internal capability for a strong PGX partnership. 10X commissioning could be just 5-6 months later.
- Pediatric data for AEZS's test and a licensing deal could happen at any time.
- AEZS pipeline assets may be nearing a clinical trial decision and candidate selection.

It could be a nice launch on NASDAQ. Add some analyst support.